Tag: Health services research
AmbulanzPartner in the trade journal NeuroTransmitter
AmbulanzPartner is featured in the current issue of the specialist journal NeuroTransmitter (1/2016 supplement). NeuroTransmitter sees itself as a discussion forum and leading professional-political medium for neurologists, neurologists and psychiatrists in Germany. As the organ of three professional associations, NeuroTransmitter is a must-read for neurologists and neurologists. Our aim with this article is to provide…
Managing Aftercare for Stroke II Study: OutpatientPartner for the recording of long-term care
In the second phase of the study on post-rehabilitative disability due to stroke and patient needs (“MAS II“), AmbulanzPartner will be used to digitally record the long-term care of the study participants. MAS II is being conducted by the Charité’s Center for Stroke Research Berlin (CSB) and will begin in June 2016. The CSB wants…
Publication of supply data in the area of medical aids from the AmbulanzPartner network
A first scientific evaluation of aggregated care data from the Outpatient Partner Network was published this month in “Der Nervenarzt” – the official publication of the German Society of Neurology (DGN). The publication analyzes data on the provision of assistive devices for patients with amyotrophic lateral sclerosis (ALS) in the period from June 2011 to…
Neurological specialist practices from Berlin new to the AmbulanzPartner network
The neurology practice in the Bismarck Karrée Prof. Dr. Andreas Kupsch and the neurology specialist practice Dr. Martin Delf in the Hoppegarten health center have been new medical partners in the AmbulanzPartner care network since the beginning of 2015. The neurology practice in the Bismarck Karrée focuses on the treatment of patients with movement disorders.…
AmbulanzPartner and Ipsen Pharma launch the world’s first research project on internet-based care management in spasticity treatment
On 1 October 2014, AmbulanzPartner and Ipsen Pharma are launching a research project to investigate the opportunities offered by digitalization and networking in complex outpatient spasticity treatment. Through AmbulanzPartner.de, all those involved in spasticity treatment are networked in terms of information technology and services. The Internet portal connects specialists, pharmacists, providers of remedies and aids…
Science prize from the German Neurological Society for the network of ALS outpatient clinics and AmbulanzPartner
During this year’s annual conference of the German Society of Neurology (DGN) in Munich, the DGN poster prize in the motor neuron and muscle diseases category was awarded to a consortium of university ALS outpatient clinics and AmbulanzPartner. The award was given for the scientific contribution ‘Provision of aidsin ALS – analysis from 3 years…
20% of people with ALS in Germany use AmbulanzPartner for their care
1,200 people with ALS in Germany currently use AmbulanzPartner for their care with remedies, aids, care services and medication. That is around 20% of all people living with ALS in Germany. This makesAmbulanzPartner the largest network for supporting people with ALS in Europe. The resulting data on care shows for the first time the differences…
AmbulanzPartner at the DEMOGRAFIEKONGRESS 2014 in Berlin
AmbulanzPartner will be presenting its internet-supported care management system at the DEMOGRAFIEKONGRESS 2014. The congress will take place from September 4 to 5, 2014 in Berlin and will focus on shaping demographic change processes in Germany. The cooperation partners of the DEMOGRAPHY CONGRESS are the German Association of Towns and Municipalities, the German County Association,…
Three years of internet-based supply management of medical aids with AmbulanzPartner – presentation at Neurowoche 2014
At the Neurowoche 2014 together with the 87th Congress of the German Society of Neurology (DGN) on September 16, 2014 in Munich, the results of three years of Internet-based care management of assistive devices in amyotrophic lateral sclerosis (ALS) with AmbulanzPartner will be presented in the scientific program.Background: ALS is a prototypical disease for the…
